Skip to Content



Conquest - Fall 2011

Latest Research Advances

Research discoveries made at MD Anderson are leading to improved therapies for cancer patients.

Here are some recent advances. Select any headline to read more about that topic.

Hope is on the horizon for current and former smokers, with findings that CT scanning may reduce lung cancer deaths by 20%.

Hagop Kantarjian, M.D., has helped draw attention to the short supply of cytarabine, the only known drug to effectively treat acute myelogenous leukemia.

A drug combining an antibody packaged with a potent chemotherapy agent has shown one of the highest response rates ever for the treatment of acute lymphoblastic leukemia.

The first positive, randomized vaccine study for advanced melanoma, and one of the first in cancer overall, has shown the benefit of using the body’s own defense system to attack tumor cells without destroying healthy tissue.

The first study comparing the benefits of yoga against those of simple stretching exercises for women with breast cancer found that patients who practiced yoga while receiving radiation therapy experienced improved physical functioning and lower levels of stress hormones.

The first comprehensive studies of genetic variations in head and neck squamous cell cancers have uncovered mutations that may help refine treatment for patients with the disease.

Researchers have developed a new test to predict which patients with newly diagnosed breast cancer have excellent probability of response and survival following chemotherapy.

Resources: Latest Research

Care to Comment?

Email the editor to comment on a story or offer suggestions on topics you'd like to see covered in future issues of Conquest and Annual Report.

Make a difference

Your gift to MD Anderson makes a difference in the lives of cancer patients by supporting innovative patient care, research, education and prevention programs. You can Donate Now or learn more at myGiving to MD Anderson.

© 2015 The University of Texas MD Anderson Cancer Center